- Reuters•20 hours ago
LONDON/DAVOS, Switzerland, Jan 19 (Reuters) - G laxoSmithKline's global head of pharmaceuticals, Abbas Hussain, is to leave Britain's biggest drugmaker after being passed over for the top job and will be replaced by Luke Miels from AstraZeneca. Hussain, the brother of former England cricket captain Nasser Hussain, had been a contender to take over from Chief Executive Andrew Witty, who steps down at the end of March, but the job went to GSK's consumer health boss Emma Walmsley.
- Reuters•9 days ago
Valeant's U.S.-listed shares (VRX.N) rose as much as 14 percent on Tuesday, before paring gains to 5.7 percent at $16.22 in afternoon trading. Laval, Quebec-based Valeant has been the subject of recent investigations by congressional panels as well as the Federal Trade Commission and the U.S. Securities and Exchange Commission. French cosmetics group L'Oreal (OREP.PA) is buying CeraVe, AcneFree and Ambi from Valeant for about $1.3 billion in cash.
- Benzinga•10 days ago
Valeant Pharmaceuticals Intl Inc (NYSE: VRX ) announced an agreement to sell its CeraVe, AcneFree and AMBI Skincare brands to L'Oreal SA (ADR) (OTC: LRLCY ) for $1.3 billion. According to Gadfly's Andrea ...
OR.PA : Summary for L''OREAL - Yahoo Finance
L'Oréal S.A. (OR.PA)
Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
|Bid||167.00 x 6000|
|Ask||169.85 x 35000|
|Day's Range||168.90 - 170.70|
|52 Week Range||146.20 - 177.90|
|PE Ratio (TTM)||33.29|
|Dividend & Yield||3.57 (1.96%)|
|1y Target Est||N/A|